Henry Schein Reports Revenue Up 9 Percent and Profits Up 8 Percent in Q1

Andrew Klips |

Health care product and service provider Henry Schein Inc. (HSIC) said Tuesday that first-quarter earnings and revenue improved on the back of increased sales both in North America and internationally. The Melville, New York-based company also affirmed its outlook for the full year.

Revenue in the first quarter for Henry Schein totaled $2.3 billion, a 9.3 percent increase from $2.1 billion in the year prior quarter. Net income in the latest quarter was $91.5 million, or $1.03 per share, up from $80.8 million, or 89 cents per share, last year. Excluding special items related a refinancing of debt at Butler Schein Animal Health, adjusted profits were $94.2 million, or $1.06 per share, an 8.2 percent increase compared to adjusted earnings in the first quarter of 2012.

Wall Street was expecting profits of $1.07 per share on revenue of $2.25 billion.

Global dental sales grew 3.0 percent to $1.2 billion. Animal health sales worldwide surged 21.6 percent to $639.1 million, with North American sales rising 14.9 percent and international sales rising 28.5 percent. Global medical sales rose by 9.6 percent to $388.9 million. Only international sales in Henry Schein’s medical segment, one of its smallest businesses, posted a decline for the quarter, dropping from $21.8 million to $21.2 million.

Global technology and value-added services increased 18.7 percent to $74.7 million, bolstered by 11.4 percent growth in North America and 14.3 percent growth overseas.

Gross margin for the quarter slipped from 29.1 percent last year to 28.2 percent.

Saying he was pleased with the quarter, Stanley M. Bergman, chairman and chief executive of Henry Schein, commented, "While the quarter's results reflect certain macroeconomic challenges in Europe, as well as some one-time technical factors, our bottom-line performance was in line with our expectations, reinforcing our confidence in the long-term outlook for the Company."

During the first quarter, the company repurchased about 840,000 shares of its stock for an aggregate of $73.5 million. As of March 31, the company still has about $227 million authorized for additional share repurchases.

For the full year 2013, Henry Schein sees earnings per share in the range of $4.81 to $4.91, representing growth of 8 percent to 11 percent over 2012.

On Monday, the company said that it now ranks #296 on the Fortune 500 list, marking the first time that it has broken under #300 since it first debuted on the list at #487 in 2004.

Shares of HSIC are up more than 20 percent in the past 52 weeks at Monday’s closing price of $91.13. In 2013 alone, shares have climbed more than 13 percent.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
HSIC Henry Schein Inc. 150.00 0.74 0.50 237,422
MTR Mesa Royalty Trust 10.50 0.04 0.38 543

Comments

Emerging Growth

Broadway Gold Mining Ltd.

Broadway Gold Mining Ltd is engaged in the exploration of mineral resources. The Company owns a 100% interest in the Madison Gold and Copper Mine located in Southwestern Montana.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Cloudera

Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…